
Sign up to save your podcasts
Or
Many people are worried that their favorite deodorant is going to cause them an early death, but when it comes down to it, we’re more worried that we’re going to smell like death. This conundrum perfectly articulates the juggling act between the short term benefit and long term risk with skin care products. In an ideal world, regulators would keep us from harm’s way. In the real world, long-term cancer risk, hormone disruption, and even organ damage are difficult to track and quantify so this is an evolving discussion. On this week’s podcast, you’ll meet the CEO of a testing company focused on safety and efficacy for manufacturers.
Listen and learn:
Links
dermatest.com
ABOUT OUR GUEST
Marcel Voss is the CEO of Dermatest GmbH, a company that specializes in skin testing and analysis.
Like the Show?
4.8
928928 ratings
Many people are worried that their favorite deodorant is going to cause them an early death, but when it comes down to it, we’re more worried that we’re going to smell like death. This conundrum perfectly articulates the juggling act between the short term benefit and long term risk with skin care products. In an ideal world, regulators would keep us from harm’s way. In the real world, long-term cancer risk, hormone disruption, and even organ damage are difficult to track and quantify so this is an evolving discussion. On this week’s podcast, you’ll meet the CEO of a testing company focused on safety and efficacy for manufacturers.
Listen and learn:
Links
dermatest.com
ABOUT OUR GUEST
Marcel Voss is the CEO of Dermatest GmbH, a company that specializes in skin testing and analysis.
Like the Show?
3,270 Listeners
1,078 Listeners
568 Listeners
12,513 Listeners
1,247 Listeners
2,444 Listeners
2,075 Listeners
4,035 Listeners
3,520 Listeners
9,350 Listeners
7,910 Listeners
610 Listeners
1,337 Listeners
28,304 Listeners
1,126 Listeners